查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2160859

2034年全球醫藥泡殼包裝箔及冷成型複合材料市場預測－依產品類型、材料類型、阻隔性、印刷格式、藥物劑型、最終用戶及地區分類的分析

Pharma Blister Foils & Cold-Forming Laminates Market Forecasts to 2034 - Global Analysis By Product Type (Blister Foils and Cold-Forming Laminates), Material Type, Barrier Level, Print Format, Pharmaceutical Dosage Form, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球醫藥泡殼膜和冷成型層壓市場規模將達到 81 億美元，並在預測期內以 7.5% 的複合年成長率成長，到 2034 年將達到 144 億美元。

藥用泡殼包裝膜和冷成型複合材料在保護藥品免受潮氣、氧氣、光照和污染等環境因素的影響方面發揮著至關重要的作用。泡殼包裝膜廣泛用於片劑和膠囊的包裝，有助於在運輸和儲存過程中維持藥品品質。冷成型複合材料通常包含一層鋁層，為敏感的藥品製劑提供優異的阻隔性能。這兩種材料均能滿足藥品包裝所需的嚴格保護和品質標準，同時保持藥物穩定性，提高包裝可靠性，延長產品保存期限，並便於劑量管理。

世界衛生組織（世衛組織）的數據顯示，世衛組織預先核准全球使用的藥品中，有60%產自印度。這凸顯了印度在藥品生產和國際供應鏈中的關鍵作用，也支撐了對可靠藥品包裝材料（包括泡殼包裝和冷成型複合材料）的需求。

藥品包裝需求不斷成長

藥品包裝需求的不斷成長顯著推動了藥品泡殼包裝和冷成型複合材料市場的發展。片劑、膠囊和固態口服藥物的日益普及，帶動了對保護性包裝材料需求的增加。泡殼包裝有助於防止藥品接觸水分、氧氣、光照和污染物，而冷成型複合材料則為需要更強阻隔性的藥品提供更優的保護。製造商越來越需要能夠保持藥品配方完整性、提升患者用藥便利性並在整個藥品供應鏈（包括運輸、儲存和分銷）中保持藥品品質的包裝。

高昂的製造成本和原料成本

生產成本和原料價格的上漲可能會限制藥品泡殼包裝和冷成型層壓板市場的成長。這些產品採用特製鋁材、聚合物層、黏合劑和精心設計的結構來實現有效的保護。對先進設備、檢測系統以及符合藥品品質標準的投資正在推高營運成本。小規模製造商可能資金籌措來維持現代化的生產能力並滿足相關標準。這些財務壓力可能導致包裝價格上漲，降低在價格敏感型市場中的競爭力，阻礙客戶接受，並對製造商的盈利能力產生負面影響。

開發永續且可回收的藥品包裝

人們對環保包裝日益成長的興趣，為醫藥泡殼包裝膜和冷成型複合包裝市場帶來了廣闊的機會。製藥公司正在尋求既能最大限度減少廢棄物，又不影響藥品品質或保護功能的解決方案。包裝供應商可以開發可回收的複合包裝材料、替代材料的組合以及便於組件分離的技術。成功實施永續包裝解決方案的企業能夠提升自身競爭力，滿足不斷變化的客戶期望，推動環保目標的實現，並擴大其在整個醫藥包裝市場的佔有率。

嚴格的監管要求和不斷變化的包裝標準

日益複雜的法規和藥品包裝指南的變更可能對藥品泡殼包裝膜和冷成型複合材料市場構成挑戰。包裝材料必須滿足藥品保護、材料相容性、性能和生產品質的嚴格要求。當標準發生變化時，供應商可能需要重新設計產品、更新生產流程並加強檢驗程序。反應遲緩的製造商可能面臨合規性問題、商業化中斷、額外成本，並在受監管市場的藥品包裝合約競爭中處於劣勢。

新型冠狀病毒（COVID-19）的影響：

新冠疫情透過改變藥品包裝要求和供應鏈狀況，對藥品泡殼包裝膜和冷塑複合市場產生了影響。基本藥物和醫療用品需求的增加，凸顯了對能夠維持藥品品質的安全包裝的需求。同時，生產中斷、物流限制、原料供應和勞動力短缺也帶來了生產挑戰。儘管面臨這些困難，包裝製造商仍努力維持穩定的生產水準。此次危機凸顯了可靠的包裝材料、靈活的生產系統和穩健的價值鏈對於藥品分銷的重要性。

在預測期內，泡殼包裝薄膜細分市場預計將佔據最大的市場佔有率。

在預測期內，泡殼包裝預計將佔據最大的市場佔有率，因為它能有效保護藥品，尤其是片劑和膠囊，免受環境因素的影響。其保護性能有助於限制藥品與水分、氧氣、光照和污染物的接觸，從而保持產品的完整性。這些材料不僅能夠實現便捷的單劑量包裝，還能確保清晰的產品標識，並在運輸和儲存過程中實現安全操作。這些功能優勢使其成為製藥公司尋求可靠保護和品質保證的首選包裝材料。

預計在預測期內，發泡錠細分市場將呈現最高的複合年成長率。

在預測期內，由於發泡錠獨特的包裝需求，預計其市場成長率將最高。由於發泡錠在服用前需溶於水，因此防潮對於防止過早反應和維持藥效至關重要。專用泡殼包裝和阻隔性複合材料有助於在儲存和運輸過程中保持穩定性。消費者對便利劑型的日益青睞以及新型劑型的不斷研發，可望推動市場對適用於發泡錠的可靠防潮包裝材料的需求。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這得益於其成熟的製藥業、完善的醫療保健系統和成熟的包裝產業。對處方藥和固態劑型的強勁需求推動了保護性泡殼包裝材料的使用。該地區還受益於其強大的製藥生產能力、經驗豐富的包裝供應商和嚴格的產品品質標準。藥物研發的持續創新和對藥物安全性的日益關注，也推動了泡殼箔和冷成型複合材料在整體製藥應用領域的需求。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於藥品產量增加、醫療保健支出上升以及藥品需求擴大。中國和印度正在大力投資生產能力和藥品包裝基礎設施。醫療保健覆蓋範圍的擴大、對經濟實惠藥品的需求以及製藥設施的建設，都在推動保護性泡殼包裝材料的使用。這些因素有望促進區域市場的擴張，並為服務亞太地區製藥企業的包裝製造商創造更多商機。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需經可行性確認）。
  • 競爭性標竿分析
    • 根據產品系列、企業發展和策略聯盟對重點公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章 全球醫藥泡殼包裝箔和冷成型層壓材料市場：依產品類型分類

  • 泡殼包裝用鋁箔
  • 冷成型層壓板

第6章 全球醫藥泡殼包裝箔和冷成型層壓材料市場：依材料類型分類

  • 鋁箔
  • 聚氯乙烯（PVC）
  • 聚醯胺
  • 聚丙烯（PP）
  • 其他材料

第7章 全球藥品泡殼包裝箔及冷成型層壓材料市場：依阻隔等級分類

  • 標準屏障
  • 高屏障
  • 超高屏障

第8章 全球醫藥泡殼包裝箔和冷成型複合材料市場：依印刷形式分類

  • 列印
  • 未印刷

第9章 全球藥品泡殼包裝箔及冷成型層壓材料市場：依藥品劑型分類

  • 藥片
  • 膠囊
  • 錠劑
  • 用於口腔黏膜的片劑
  • 發泡錠

第10章 全球醫藥泡殼包裝箔和冷成型層壓材料市場：依最終用戶分類

  • 製藥公司
  • 合約包裝營運商 (CPO)

第11章 全球醫藥泡殼包裝箔和冷成型層壓材料市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第12章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第13章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第14章：公司簡介

  • Amcor plc
  • Constantia Flexibles
  • Bilcare Research
  • Tekni-Plex
  • UFlex Limited
  • ACG Pharmapack
  • Klockner Pentaplast
  • Perlen Packaging
  • Honeywell International Inc.
  • Sonoco Products Company
  • Huhtamaki Oyj
  • Aluflexpack
  • Svam Toyal Packaging Industries Pvt. Ltd.
  • Ningbo Dragon Packaging Technology Co., Ltd.
  • Haishun New Pharmaceutical Packaging Ltd.
  • Rollprint Packaging Products, Inc.
  • Winpak Ltd.
  • Jindal Poly Films
Product Code: SMRC40219

According to Stratistics MRC, the Global Pharma Blister Foils & Cold-Forming Laminates Market is accounted for $8.1 billion in 2026 and is expected to reach $14.4 billion by 2034 growing at a CAGR of 7.5% during the forecast period. Pharmaceutical blister foils and cold-forming laminates play a crucial role in safeguarding medicines against environmental exposure, including humidity, oxygen, light, and contamination. Blister foils are widely used to package tablets and capsules while preserving their quality during transportation and storage. Cold-forming laminates generally incorporate aluminum layers to deliver superior barrier performance for sensitive pharmaceutical formulations. Both materials help maintain medicine stability, improve packaging reliability, extend product usability, and facilitate convenient dose management while supporting the stringent protection and quality standards required in pharmaceutical packaging.

According to the World Health Organization (WHO), India is the origin of 60% of medicines prequalified by WHO for global use. This demonstrates India's important role in pharmaceutical manufacturing and international medicine supply, supporting the need for dependable pharmaceutical packaging materials, including blister foils and cold-forming laminates.

Market Dynamics:

Driver:

Growing demand for pharmaceutical packaging

Rising pharmaceutical packaging requirements are contributing significantly to the growth of the Pharma Blister Foils & Cold-Forming Laminates Market. Greater use of tablets, capsules, and solid oral medications increases the demand for protective packaging materials. Blister foils help prevent exposure to humidity, oxygen, light, and contaminants, whereas cold-forming laminates offer superior protection for medicines requiring stronger barriers. Manufacturers increasingly seek packaging that maintains formulation integrity, improves patient convenience, and preserves medicine quality during transportation, storage, and distribution across pharmaceutical supply chains.

Restraint:

High manufacturing and material costs

Elevated production expenses and raw material prices can limit growth in the Pharma Blister Foils & Cold-Forming Laminates Market. Manufacturing these products involves specialized aluminum, polymer layers, adhesives, and carefully engineered structures that deliver effective protection. Investment in sophisticated machinery, inspection systems, and pharmaceutical quality compliance adds to operational costs. Smaller manufacturers may struggle to finance modern production capabilities while meeting required standards. These financial pressures can increase packaging prices, reduce competitiveness in budget-conscious markets, constrain customer adoption, and negatively influence manufacturers' profitability.

Opportunity:

Development of sustainable and recyclable pharmaceutical packaging

Growing interest in environmentally responsible packaging creates promising opportunities in the Pharma Blister Foils & Cold-Forming Laminates Market. Pharmaceutical manufacturers are seeking solutions that minimize waste without compromising medicine quality or protection. Packaging suppliers can develop recyclable laminates, alternative material combinations, and technologies that facilitate component separation. Companies that successfully introduce sustainable packaging solutions may improve their competitive position, meet evolving customer expectations, advance environmental goals, and expand their presence across pharmaceutical packaging markets.

Threat:

Stringent regulatory requirements and changing packaging standards

Increasing regulatory complexity and changing pharmaceutical packaging guidelines can create challenges for the Pharma Blister Foils & Cold-Forming Laminates Market. Packaging materials must satisfy rigorous requirements concerning medicine protection, material suitability, performance, and manufacturing quality. When standards change, suppliers may need to redesign products, update production methods, and strengthen verification procedures. Manufacturers that respond slowly may face compliance difficulties, interrupted commercialization, additional expenses, and disadvantages when competing for pharmaceutical packaging contracts in regulated markets.

Covid-19 Impact:

The COVID-19 outbreak affected the Pharma Blister Foils & Cold-Forming Laminates Market through changing pharmaceutical packaging requirements and supply chain conditions. Increased demand for essential drugs and healthcare supplies strengthened the need for secure packaging that preserves medicine quality. Meanwhile, manufacturing interruptions, logistical restrictions, limited raw material availability, and labour shortages created production difficulties. Packaging companies worked to maintain consistent output despite these obstacles. The crisis emphasized the value of reliable packaging materials, flexible manufacturing operations, and stronger supply chains for pharmaceutical distribution.

The blister foils segment is expected to be the largest during the forecast period

The blister foils segment is expected to account for the largest market share during the forecast period by safeguarding medicines, especially tablets and capsules, from environmental exposure. Their protective characteristics help maintain product integrity by limiting contact with humidity, oxygen, light, and contaminants. These materials enable practical unit-dose packaging while supporting clear product identification and safe handling during transportation and storage. These functional advantages make them a preferred packaging material for pharmaceutical companies seeking dependable medicine protection and quality preservation.

The effervescent tablets segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the effervescent tablets segment is predicted to witness the highest growth rate due to their specific packaging requirements. Since these tablets dissolve in water before consumption, protecting them from humidity is essential to prevent premature reactions and preserve effectiveness. Specialized blister foils and high-barrier laminates help maintain stability during storage and distribution. Increasing consumer preference for convenient medicine formats and continued development of alternative dosage formulations may support demand for reliable moisture-protective packaging materials suitable for effervescent pharmaceutical products.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by its mature pharmaceutical sector, developed healthcare systems, and established packaging industry. Strong demand for prescription medicines and solid-dose drugs encourages the use of protective blister packaging materials. The region also benefits from pharmaceutical manufacturing capabilities, experienced packaging suppliers, and strict product quality expectations. Continued innovation in drug development and increasing attention to medicine safety help sustain demand for blister foils and cold-forming laminates across pharmaceutical applications.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR due to increasing pharmaceutical production, rising healthcare spending, and expanding demand for medicines. China and India are investing in manufacturing capabilities and pharmaceutical packaging infrastructure. Growing access to medical treatments, demand for cost-effective drugs, and development of pharmaceutical facilities are encouraging greater use of protective blister packaging materials. These factors may support regional market expansion and create additional opportunities for packaging manufacturers serving pharmaceutical companies throughout Asia Pacific.

Key players in the market

Some of the key players in Pharma Blister Foils & Cold-Forming Laminates Market include Amcor plc, Constantia Flexibles, Bilcare Research, Tekni-Plex, UFlex Limited, ACG Pharmapack, Klockner Pentaplast, Perlen Packaging, Honeywell International Inc., Sonoco Products Company, Huhtamaki Oyj, Aluflexpack, Svam Toyal Packaging Industries Pvt. Ltd., Ningbo Dragon Packaging Technology Co., Ltd., Haishun New Pharmaceutical Packaging Ltd., Rollprint Packaging Products, Inc., Winpak Ltd. and Jindal Poly Films.

Key Developments:

In July 2026, Sonoco Products Company announced continued investment to expand its Wood Reels manufacturing and assembly footprint to meet a surge in demand for power and communications cable packaging driven by AI data center growth and power grid modernization.

In April 2025, Amcor plc announced the successful completion of its all-stock combination with Berry Global, effective. Through this combination, Amcor enhances its position as a global leader in consumer and healthcare packaging solutions with the unique material science and innovation capabilities required to revolutionize product development and meet customers' and consumers' sustainability aspirations.

Product Types Covered:

  • Blister Foils
  • Cold-Forming Laminates

Material Types Covered:

  • Aluminum Foil
  • Polyvinyl Chloride (PVC)
  • Polyamide
  • Polypropylene (PP)
  • Other Materials

Barrier Levels Covered:

  • Standard Barrier
  • High Barrier
  • Ultra-High Barrier

Print Formats Covered:

  • Printed
  • Unprinted

Pharmaceutical Dosage Forms Covered:

  • Tablets
  • Capsules
  • Lozenges
  • Buccal Tablets
  • Effervescent Tablets

End Users Covered:

  • Pharmaceutical Manufacturers
  • Contract Packaging Organizations (CPOs)

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Pharma Blister Foils & Cold-Forming Laminates Market, By Product Type

  • 5.1 Blister Foils
  • 5.2 Cold-Forming Laminates

6 Global Pharma Blister Foils & Cold-Forming Laminates Market, By Material Type

  • 6.1 Aluminum Foil
  • 6.2 Polyvinyl Chloride (PVC)
  • 6.3 Polyamide
  • 6.4 Polypropylene (PP)
  • 6.5 Other Materials

7 Global Pharma Blister Foils & Cold-Forming Laminates Market, By Barrier Level

  • 7.1 Standard Barrier
  • 7.2 High Barrier
  • 7.3 Ultra-High Barrier

8 Global Pharma Blister Foils & Cold-Forming Laminates Market, By Print Format

  • 8.1 Printed
  • 8.2 Unprinted

9 Global Pharma Blister Foils & Cold-Forming Laminates Market, By Pharmaceutical Dosage Form

  • 9.1 Tablets
  • 9.2 Capsules
  • 9.3 Lozenges
  • 9.4 Buccal Tablets
  • 9.5 Effervescent Tablets

10 Global Pharma Blister Foils & Cold-Forming Laminates Market, By End User

  • 10.1 Pharmaceutical Manufacturers
  • 10.2 Contract Packaging Organizations (CPOs)

11 Global Pharma Blister Foils & Cold-Forming Laminates Market, By Geography

  • 11.1 North America
    • 11.1.1 United States
    • 11.1.2 Canada
    • 11.1.3 Mexico
  • 11.2 Europe
    • 11.2.1 United Kingdom
    • 11.2.2 Germany
    • 11.2.3 France
    • 11.2.4 Italy
    • 11.2.5 Spain
    • 11.2.6 Netherlands
    • 11.2.7 Belgium
    • 11.2.8 Sweden
    • 11.2.9 Switzerland
    • 11.2.10 Poland
    • 11.2.11 Rest of Europe
  • 11.3 Asia Pacific
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 South Korea
    • 11.3.5 Australia
    • 11.3.6 Indonesia
    • 11.3.7 Thailand
    • 11.3.8 Malaysia
    • 11.3.9 Singapore
    • 11.3.10 Vietnam
    • 11.3.11 Rest of Asia Pacific
  • 11.4 South America
    • 11.4.1 Brazil
    • 11.4.2 Argentina
    • 11.4.3 Colombia
    • 11.4.4 Chile
    • 11.4.5 Peru
    • 11.4.6 Rest of South America
  • 11.5 Rest of the World (RoW)
    • 11.5.1 Middle East
      • 11.5.1.1 Saudi Arabia
      • 11.5.1.2 United Arab Emirates
      • 11.5.1.3 Qatar
      • 11.5.1.4 Israel
      • 11.5.1.5 Rest of Middle East
    • 11.5.2 Africa
      • 11.5.2.1 South Africa
      • 11.5.2.2 Egypt
      • 11.5.2.3 Morocco
      • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

  • 12.1 Industry Value Network and Supply Chain Assessment
  • 12.2 White-Space and Opportunity Mapping
  • 12.3 Product Evolution and Market Life Cycle Analysis
  • 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

  • 13.1 Mergers and Acquisitions
  • 13.2 Partnerships, Alliances, and Joint Ventures
  • 13.3 New Product Launches and Certifications
  • 13.4 Capacity Expansion and Investments
  • 13.5 Other Strategic Initiatives

14 Company Profiles

  • 14.1 Amcor plc
  • 14.2 Constantia Flexibles
  • 14.3 Bilcare Research
  • 14.4 Tekni-Plex
  • 14.5 UFlex Limited
  • 14.6 ACG Pharmapack
  • 14.7 Klockner Pentaplast
  • 14.8 Perlen Packaging
  • 14.9 Honeywell International Inc.
  • 14.10 Sonoco Products Company
  • 14.11 Huhtamaki Oyj
  • 14.12 Aluflexpack
  • 14.13 Svam Toyal Packaging Industries Pvt. Ltd.
  • 14.14 Ningbo Dragon Packaging Technology Co., Ltd.
  • 14.15 Haishun New Pharmaceutical Packaging Ltd.
  • 14.16 Rollprint Packaging Products, Inc.
  • 14.17 Winpak Ltd.
  • 14.18 Jindal Poly Films

List of Tables

  • Table 1 Global Pharma Blister Foils & Cold-Forming Laminates Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Pharma Blister Foils & Cold-Forming Laminates Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 3 Global Pharma Blister Foils & Cold-Forming Laminates Market Outlook, By Blister Foils (2023-2034) ($MN)
  • Table 4 Global Pharma Blister Foils & Cold-Forming Laminates Market Outlook, By Cold-Forming Laminates (2023-2034) ($MN)
  • Table 5 Global Pharma Blister Foils & Cold-Forming Laminates Market Outlook, By Material Type (2023-2034) ($MN)
  • Table 6 Global Pharma Blister Foils & Cold-Forming Laminates Market Outlook, By Aluminum Foil (2023-2034) ($MN)
  • Table 7 Global Pharma Blister Foils & Cold-Forming Laminates Market Outlook, By Polyvinyl Chloride (PVC) (2023-2034) ($MN)
  • Table 8 Global Pharma Blister Foils & Cold-Forming Laminates Market Outlook, By Polyamide (2023-2034) ($MN)
  • Table 9 Global Pharma Blister Foils & Cold-Forming Laminates Market Outlook, By Polypropylene (PP) (2023-2034) ($MN)
  • Table 10 Global Pharma Blister Foils & Cold-Forming Laminates Market Outlook, By Other Materials (2023-2034) ($MN)
  • Table 11 Global Pharma Blister Foils & Cold-Forming Laminates Market Outlook, By Barrier Level (2023-2034) ($MN)
  • Table 12 Global Pharma Blister Foils & Cold-Forming Laminates Market Outlook, By Standard Barrier (2023-2034) ($MN)
  • Table 13 Global Pharma Blister Foils & Cold-Forming Laminates Market Outlook, By High Barrier (2023-2034) ($MN)
  • Table 14 Global Pharma Blister Foils & Cold-Forming Laminates Market Outlook, By Ultra-High Barrier (2023-2034) ($MN)
  • Table 15 Global Pharma Blister Foils & Cold-Forming Laminates Market Outlook, By Print Format (2023-2034) ($MN)
  • Table 16 Global Pharma Blister Foils & Cold-Forming Laminates Market Outlook, By Printed (2023-2034) ($MN)
  • Table 17 Global Pharma Blister Foils & Cold-Forming Laminates Market Outlook, By Unprinted (2023-2034) ($MN)
  • Table 18 Global Pharma Blister Foils & Cold-Forming Laminates Market Outlook, By Pharmaceutical Dosage Form (2023-2034) ($MN)
  • Table 19 Global Pharma Blister Foils & Cold-Forming Laminates Market Outlook, By Tablets (2023-2034) ($MN)
  • Table 20 Global Pharma Blister Foils & Cold-Forming Laminates Market Outlook, By Capsules (2023-2034) ($MN)
  • Table 21 Global Pharma Blister Foils & Cold-Forming Laminates Market Outlook, By Lozenges (2023-2034) ($MN)
  • Table 22 Global Pharma Blister Foils & Cold-Forming Laminates Market Outlook, By Buccal Tablets (2023-2034) ($MN)
  • Table 23 Global Pharma Blister Foils & Cold-Forming Laminates Market Outlook, By Effervescent Tablets (2023-2034) ($MN)
  • Table 24 Global Pharma Blister Foils & Cold-Forming Laminates Market Outlook, By End User (2023-2034) ($MN)
  • Table 25 Global Pharma Blister Foils & Cold-Forming Laminates Market Outlook, By Pharmaceutical Manufacturers (2023-2034) ($MN)
  • Table 26 Global Pharma Blister Foils & Cold-Forming Laminates Market Outlook, By Contract Packaging Organizations (CPOs) (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.